Sara Sadr

Sara Sadr

Auto-generated profile, based on publicly available information

Sara Sadr

School of Medicine Mazandaran University of Medical Sciences Sari Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
ESEhsan Sekhavati
Ehsan Sekhavati
FJFatemeh Jafari
Fatemeh Jafari
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
SJSaeidreza Jamalimoghadamsiahkali
Saeidreza Jamalimoghadamsiahkali
SSSara Sadr
Sara Sadr
FGFereshteh Ghiasvand
Fereshteh Ghiasvand

1 January 2020 in IDCases
Verified
Journal Article
Open access
SSSara Sadr
Sara Sadr
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
FGFereshteh Ghiasvand
Fereshteh Ghiasvand
MNMalihe Hassan Nezhad
Malihe Hassan Nezhad
NJNina Javadian
Nina Javadian
FJFatemeh Jafari
Fatemeh Jafari
COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such as hematopoietic, neurological and the immune system. In this report, we described a case of a COVID-19 patient who presented with no pulmonary involvement but severe thrombocytopenia. She suffered from headache and malaise with no respiratory symptoms, fever or chills. Chest radiological imaging was unremarkable but, the laboratory results showed significant thrombocytopenia associated with relatively decreased lymphocytes. Based on her high-risk work environment, a reverse transcription polymerase chain reaction (RT-PCR) test was performed and SARS-CoV-2 RNA was detected in the nasopharyngeal swab. Complete blood count (CBC) of patient was re-checked during admission and platelet count showed rising trend up to normal levels. A narrow diagnostic approach where only febrile patients with pulmonary symptoms are evaluated for a COVID-19 diagnosis will result in many missed diagnoses; so it is important that physicians are familiar with atypical and rare presentations of COVID-19, such as isolated thrombocytopenia.

22 March 2023 in Nursing Open
Verified
Journal Article
Open access
SSSara Sadr
Sara Sadr
MMMaryam Mobini
Maryam Mobini
MTMohammad Tabarestani
Mohammad Tabarestani
PPParisa Islami Parkoohi
Parisa Islami Parkoohi
FEForouzan Elyasi
Forouzan Elyasi
Aim: This study aimed to investigate psychiatric disorders in Iranian female patients with fibromyalgia (FM).Design: Female patients, newly diagnosed with FM, were interviewed by a psychiatrist for psychiatric assessments during a 2‐year period.Methods: The diagnosis of the psychiatric disorders was based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5), and sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI).Results: In total, 159 patients with the mean age of 42.15 ± 9.89 were recruited in this study. Over 92% of the cases were also diagnosed with at least one type of psychiatric disorder. Sleep disorders (SDs, 90.57%), mood disorders (MDs, 52.83%), personality disorders (PDs, 40.25%) and anxiety disorders (ADs, 16.98%) were the most prevalent diagnoses among these patients. The logistic regression results correspondingly showed that suffering from Cluster‐B PDs was associated with a higher prevalence rate of somatic symptom disorders (SSDs), with a p‐value of 0.019 and an odds ratio (OR) of 2.7.

1 November 2021 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
SSSara Sadr
Sara Sadr
MBMelika Arab Bafrani
Melika Arab Bafrani
AAAlireza Abdollahi
Alireza Abdollahi
SSSeyed Ahmad SeyedAlinaghi
Seyed Ahmad SeyedAlinaghi
EMEsmaeil Mohammadnejad
Esmaeil Mohammadnejad
FGFereshteh Ghiasvand
Fereshteh Ghiasvand
Background Possibility of reinfection with SARS-CoV-2 changes our view on herd immunity and vaccination and can impact worldwide quarantine policies. We performed real-time polymerase chain reaction (RT-PCR) follow-up studies on recovered patients to assess possible development of reinfections and re-positivity. Methods During a 6-month period, 202 PCR-confirmed recovering COVID-19 patients entered this study. Follow-up RT-PCR tests and symptom assessment were performed 1 month after the initial positive results. Patients who tested negative were tested again 1 and 3 months later. The serum IgG and IgM levels were measured in the last follow-up session. Results In the first two follow-up sessions, 82 patients continued their participation, of which four patients tested positive. In the second follow-up 44 patients participated, three of whom tested positive. None of the patients who tested positive in the first and second follow-up session were symptomatic. In the last session, 32 patients were tested and four patients were positive, three of them were mildly symptomatic and all of them were positive for IgG. Conclusions A positive RT-PCR in a recovering patient may represent reinfection. While we did not have the resources to prove reinfection by genetic sequencing of the infective viruses, we believe presence of mild symptoms in the three patients who tested positive over 100 days after becoming asymptomatic, can be diagnosed as reinfection. The immune response developed during the first episode of infection (e.g., IgG or T-cell mediated responses that were not measured in our study) may have abated the symptoms of the reinfection, without providing complete protection.

16 May 2021
Verified
Preprint
Open access
PDF file
SSSara Sadr
Sara Sadr
MBMelika Arab Bafrani
Melika Arab Bafrani
AAAlireza Abdollahi
Alireza Abdollahi
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
EMEsmaeil Mohammadnejad
Esmaeil Mohammadnejad
FGFereshteh Ghiasvand
Fereshteh Ghiasvand
Objectives Possibility of reinfection with SARS-CoV-2 changes our view on herd immunity and vaccination, and can impact worldwide quarantine policies. We performed RT-PCR follow-up studies on recovered patients to assess possible development of reinfections and re-positivity. Method During a 6-month period, 202 PCR-confirmed recovering COVID-19 patients entered this study. Follow-up RT-PCR tests and symptoms assessment were performed one month after the initial Positive results. patients who tested negative were tested again one and three months later. The Serum IgG and IgM levels were measured in the last follow-up session. Results In the first two follow-up sessions, 82 patients continued their participation, of which four patients tasted positive. In the second follow-up 44 patients participated, three of whom tested positive. None of the patients who tested positive in the first and second follow-up session were symptomatic. In the last session, 32 patients were tested and four patients were positive, three of them were mildly symptomatic and all of them were positive for IgG. Conclusion A positive RT-PCR in a recovering patient may represent reinfection. While we did not have the resources to prove reinfection by genetic sequencing of the infective viruses, we believe presence of mild symptoms in the three patients who tested positive over 100 days after becoming asymptomatic, can be diagnosed as reinfection. The IgG may have abated the symptoms of the reinfection, without providing complete protection.